Esophageal Hypervigilance and Visceral Anxiety Are Contributors to Symptom Severity Among Patients Evaluated With High-Resolution Esophageal Manometry.


Journal

The American journal of gastroenterology
ISSN: 1572-0241
Titre abrégé: Am J Gastroenterol
Pays: United States
ID NLM: 0421030

Informations de publication

Date de publication:
03 2020
Historique:
pubmed: 29 1 2020
medline: 6 5 2020
entrez: 29 1 2020
Statut: ppublish

Résumé

Symptoms are inconsistently associated with esophageal motor findings on high-resolution manometry (HRM). We aimed to evaluate predictors of dysphagia severity, including esophageal hypervigilance and visceral anxiety, among patients evaluated with HRM. Adult patients undergoing HRM at 4 academic medical centers (United States and France) were prospectively evaluated. HRM was completed and analyzed per the Chicago Classification v3.0. Validated symptom scores, including the Brief Esophageal Dysphagia Questionnaire and Esophageal Hypervigilance and Anxiety Scale, were completed at the time of HRM. Two hundred thirty-six patients, aged 18-85 (mean 53) years, 65% female, were included. Approximately 59 (25%) patients had a major motor disorder on HRM: 19 achalasia, 24 esophagogastric junction outflow obstruction, 12 absent contractility, and 4 jackhammer. Approximately 177 (75%) patients did not have a major motor disorder: 71 ineffective esophageal motility and 106 normal motility. Having a major motor disorder was a significant predictor of dysphagia severity (Radj = 0.049, P < 0.001), but the Esophageal Hypervigilance and Anxiety Scale score carried a predictive relationship of Brief Esophageal Dysphagia Questionnaire that was 2-fold higher than having a major motor disorder: Radj = 0.118 (P < 0.001). This finding remained when evaluated by the major motor disorder group. HRM metrics were nonsignificant. In a prospective, international multicenter study, we found that esophageal hypervigilance and visceral anxiety were the strongest predictors of dysphagia severity among patients evaluated with HRM. Thus, an assessment of esophageal hypervigilance and visceral anxiety is important to incorporate when evaluating symptom severity in clinical practice and research studies.

Identifiants

pubmed: 31990697
doi: 10.14309/ajg.0000000000000536
pmc: PMC7071929
mid: NIHMS1566568
pii: 00000434-202003000-00013
doi:

Types de publication

Clinical Trial Journal Article Multicenter Study Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

367-375

Subventions

Organisme : NIDDK NIH HHS
ID : P01 DK117824
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK079902
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001422
Pays : United States

Références

Neurogastroenterol Motil. 2015 Feb;27(2):160-74
pubmed: 25469569
Aliment Pharmacol Ther. 2018 May;47(9):1270-1277
pubmed: 29528128
Neurogastroenterol Motil. 2016 Dec;28(12):1854-1860
pubmed: 27380834
Neurogastroenterol Motil. 2019 Feb;31(2):e13505
pubmed: 30426609
Neurogastroenterol Motil. 2014 Feb;26(2):168-75
pubmed: 24164976
United European Gastroenterol J. 2013 Aug;1(4):249-58
pubmed: 24917969
Aliment Pharmacol Ther. 2007 Sep 1;26(5):683-91
pubmed: 17697202
Scand J Gastroenterol. 1995 Jan;30(1):1-5
pubmed: 7701244
Clin Gastroenterol Hepatol. 2019 Mar;17(4):674-681.e1
pubmed: 30081222
Am J Gastroenterol. 2018 Jan;113(1):31-38
pubmed: 28895583
Am J Gastroenterol. 2014 Apr;109(4):521-6
pubmed: 24513804
Clin Gastroenterol Hepatol. 2015 Jun;13(6):1089-95.e1
pubmed: 25496817
Neurogastroenterol Motil. 2017 Sep;29(9):
pubmed: 28480513
Aliment Pharmacol Ther. 2007 Aug 1;26(3):443-52
pubmed: 17635379
N Engl J Med. 1983 Dec 1;309(22):1337-42
pubmed: 6633595
Neurogastroenterol Motil. 2017 Apr;29(4):
pubmed: 27723241
Aliment Pharmacol Ther. 2013 Mar;37(5):564-72
pubmed: 23289763
Am J Gastroenterol. 2008 Jan;103(1):27-37
pubmed: 17900331

Auteurs

Dustin A Carlson (DA)

Division of Gastroenterology and Hepatology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.

C Prakash Gyawali (CP)

Division of Gastroenterology, Washington University School of Medicine, St. Louis, Missouri, USA.

Sabine Roman (S)

Université de Lyon, Hospices Civils de Lyon, Digestive Physiology, Hopital E Herriot, Lyon, France; Université de Lyon, Lyon I University, Digestive Physiology, Lyon, France; Université de Lyon, Inserm U1032, LabTAU, Lyon, France.

Marcelo Vela (M)

Division of Gastroenterology, Mayo Clinic, Scottsdale, Arizona, USA.

Tiffany H Taft (TH)

Division of Gastroenterology and Hepatology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.

Michael D Crowell (MD)

Division of Gastroenterology, Mayo Clinic, Scottsdale, Arizona, USA.

Karthik Ravi (K)

Division of Gastroenterology, Mayo Clinic, Rochester, Minnesota, USA.

Joseph R Triggs (JR)

Division of Gastroenterology and Hepatology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.

Farhan Quader (F)

Division of Gastroenterology, Washington University School of Medicine, St. Louis, Missouri, USA.

Jacqueline Prescott (J)

Division of Gastroenterology and Hepatology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.

Frederick T J Lin (FTJ)

Division of Gastroenterology and Hepatology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.

Francois Mion (F)

Université de Lyon, Hospices Civils de Lyon, Digestive Physiology, Hopital E Herriot, Lyon, France; Université de Lyon, Lyon I University, Digestive Physiology, Lyon, France; Université de Lyon, Inserm U1032, LabTAU, Lyon, France.

Dario Biasutto (D)

Université de Lyon, Hospices Civils de Lyon, Digestive Physiology, Hopital E Herriot, Lyon, France; Université de Lyon, Lyon I University, Digestive Physiology, Lyon, France; Université de Lyon, Inserm U1032, LabTAU, Lyon, France.

Laurie Keefer (L)

Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Peter J Kahrilas (PJ)

Division of Gastroenterology and Hepatology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.

John E Pandolfino (JE)

Division of Gastroenterology and Hepatology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH